23,99 €
inkl. MwSt.

Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Mesenchymal stem cells (MSCs) are characterized by high angiogenic power, and are understood to be beneficial against endothelial dysfunction. This study investigates the impact of the transplantation of allogeneic MSCs from adult bone marrow on microvascular rarefaction, endothelial dysfunction, and hypertension in rats. Results suggest that MSCs present a promising treatment strategy against hypertension. The mechanism appears to not involve changes of microvascular circulation.

Produktbeschreibung
Mesenchymal stem cells (MSCs) are characterized by high angiogenic power, and are understood to be beneficial against endothelial dysfunction. This study investigates the impact of the transplantation of allogeneic MSCs from adult bone marrow on microvascular rarefaction, endothelial dysfunction, and hypertension in rats. Results suggest that MSCs present a promising treatment strategy against hypertension. The mechanism appears to not involve changes of microvascular circulation.
Autorenporträt
Il Prof Dr. Loss ha conseguito un dottorato (2012) in Patologia Clinica (Fisiopatologia dell'ipertensione) presso l'Universidade Federal do Triangulo Mineiro-UFTM, in Brasile. Ha completato la ricerca post-dottorato sulla variabilità della frequenza cardiaca presso l'Università di Milano, in Italia, e attualmente è professore aggiunto e ricercatore presso l'UFTM, in Brasile.